- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
U
UNCY
Unicycive Therapeutics Inc
8.08
+0.45+5.90%After Hours: 8.16 +0.08 +0.97%19:09 05/22 EDT
OPEN/PREV CLOSE7.66/7.63
TODAY RANGE7.66-8.23
VOL591.94K
MARKET CAP215.74M
52 WEEK RANGE3.710-11.00
AVG VOL (3M)536.63K
% TURNOVER2.22%
TURNOVER--
P/E (TTM)-3.8893
% RANGE7.34%
EPS(TTM)-2.0775
P/E(FORWARD)-6.2636
P/B5.41
BVPS1.494
DIVIDEND--
P/S318.56
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP210.65M
SHARES OUTSTANDING26.70M
NEXT EARNINGS08/12-08/17
FREE FLOAT26.07M
LOT SIZE1
EX-DATE06/20/2025
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3d ago
Unicycive Therapeutics: A Catalyst Play With Real Fundamental Upside
Seeking Alpha·05/14 18:40
Biopharmas look to China, elsewhere for partnerships, R&D
Dow Jones·05/13 14:00
Unicycive Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones·05/13 14:00
Unicycive Therapeutics Price Target Cut to $37.00/Share From $40.00 by Guggenheim
TipRanks·05/13 13:56
Noble Financial Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY)
Benzinga·05/13 13:49
Guggenheim Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $37
TipRanks·05/13 11:14
Unicycive Therapeutics price target lowered to $37 from $40 at Guggenheim
TipRanks·05/12 11:51
Unicycive Therapeutics reports Q1 EPS (50c), consensus (47c)
Benzinga·05/12 11:48
Unicycive Therapeutics Q1 EPS $(0.54) Misses $(0.51) Estimate
Seeking Alpha·05/12 11:33
Unicycive Therapeutics GAAP EPS of -$0.54 misses by $0.08
Dow Jones·05/12 11:13
*Unicycive Therapeutics: Runway To Fund Planned Operations Into 2027 >UNCY
Reuters·05/12 11:12
Unicycive Therapeutics Q1 net loss widens on warrant liability
Dow Jones·05/12 11:05
Press Release: Unicycive Therapeutics Announces -2-